Risk factors for cerebrovascular events following Fontan palliation in patients with a functional single ventricle

被引:27
作者
Barker, PCA
Nowak, C
King, K
Mosca, RS
Bove, EL
Goldberg, CS [1 ]
机构
[1] Univ Michigan, Div Pediat Cardiol, Dept Pediat, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sect Cardiac Surg, Dept Surg, Ann Arbor, MI 48109 USA
关键词
D O I
10.1016/j.amjcard.2005.04.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The risk for cerebrovascular events (CVEs) is increased in children with functional single ventricles (FSVs). However, there are limited data indicating the prevalence of CVEs or the role of preventative therapy. To measure the prevalence of clinically evident CVEs in patients with FSVs, identify risk factors, and analyze the effect of aspirin on the risk for CVEs, a retrospective chart review was performed on all patients who underwent Fontan palliation at, the University of Michigan from January 1, 1975, to June 30, 1998 (n = 402). Data collected included original anatomy, Fontan type, date of CVE, medications at the time of CVE, intraoperative placement of fenestration, and date of last follow-up. The overall mortality rate was 12%. There were 38 CVEs (9%), of which only 11 (3%, or 0.0.036/patient-year) could not be attributed to a defined event (catheterization, extracorporeal membrane oxygenation, or cardiac arrest). Anticoagulation with aspirin was associated with a statistically significantly decreased risk for CVEs. Fontan type was not associated with the risk for CVEs. Thus, patients with FSVs are at increased risk for CVEs, although the de novo risk was low. Aspirin use is associated with a decreased risk for CVEs. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:587 / 591
页数:5
相关论文
共 20 条
[1]   COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]   Intracardiac thrombus formation after the Fontan operation [J].
Balling, G ;
Vogt, M ;
Kaemmerer, H ;
Eicken, A ;
Meisner, H ;
Hess, J .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2000, 119 (04) :745-751
[3]   COAGULATION-FACTOR ABNORMALITIES AS POSSIBLE THROMBOTIC RISK-FACTORS AFTER FONTAN OPERATIONS [J].
CROMMEDIJKHUIS, AH ;
HENKENS, CMA ;
BIJLEVELD, CMA ;
HILLEGE, HL ;
BOM, VJJ ;
VANDERMEER, J .
LANCET, 1990, 336 (8723) :1087-1090
[4]   SPECIFIC SEQUELAE AFTER FONTAN OPERATION AT MIDTERM AND LONG-TERM FOLLOW-UP - ARRHYTHMIA, LIVER DYSFUNCTION, AND COAGULATION DISORDERS [J].
CROMMEDIJKHUIS, AH ;
HESS, J ;
HAHLEN, K ;
HENKENS, CMA ;
BINKBOELKENS, MTE ;
EYGELAAR, AA ;
BOS, E .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1993, 106 (06) :1126-1132
[5]   FACTORS ASSOCIATED WITH STROKE FOLLOWING THE FONTAN PROCEDURE [J].
DAY, RW ;
BOYER, RS ;
TAIT, VF ;
RUTTENBERG, HD .
PEDIATRIC CARDIOLOGY, 1995, 16 (06) :270-275
[6]   CEREBROVASCULAR ACCIDENTS FOLLOWING THE FONTAN OPERATION [J].
DUPLESSIS, AJ ;
CHANG, AC ;
WESSEL, DL ;
LOCK, JE ;
WERNOVSKY, G ;
NEWBURGER, JW ;
MAYER, JE .
PEDIATRIC NEUROLOGY, 1995, 12 (03) :230-236
[7]   CLINICAL SPECTRUM OF VENOUS THROMBI IN THE FONTAN PATIENT [J].
FLETCHER, SE ;
CASE, CL ;
FYFE, DA ;
GILLETTE, PC .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (17) :1721-1722
[8]   TRANSESOPHAGEAL ECHOCARDIOGRAPHY DETECTS THROMBUS FORMATION NOT IDENTIFIED BY TRANSTHORACIC ECHOCARDIOGRAPHY AFTER THE FONTAN OPERATION [J].
FYFE, DA ;
KLINE, CH ;
SADE, RM ;
GILLETTE, PC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (07) :1733-1737
[9]   Aspirin for the primary prevention of stroke and other major vascular events - Meta-analysis and hypotheses [J].
Hart, RG ;
Halperin, JL ;
McBride, R ;
Benavente, O ;
Man-Son-Hing, M ;
Kronmal, RA .
ARCHIVES OF NEUROLOGY, 2000, 57 (03) :326-332
[10]   THROMBOEMBOLISM AFTER THE FONTAN PROCEDURE AND ITS MODIFICATIONS [J].
JAHANGIRI, M ;
ROSS, DB ;
REDINGTON, AN ;
LINCOLN, C ;
SHINEBOURNE, EA .
ANNALS OF THORACIC SURGERY, 1994, 58 (05) :1409-1413